QT variability in amyloidosis of familial Mediterranean fever

Udi Nussinovitch1, Ilan Ben-Zvi, Avi Livneh

  • 1Israel Naval Medical Institute, Israel Defense Forces Medical Corps, Haifa, Israel.

Abstract

Insights

Familial Mediterranean Fever (FMF) with amyloidosis shows higher QT variability index (QTVI), a marker of heart rhythm issues. This finding may indicate increased arrhythmia risk in these patients.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
  • The link between FMF and ventricular arrhythmias is not well-established.
  • Amyloidosis is a potential complication of FMF, affecting organs including the heart.

Purpose of the Study:

  • To assess QT variability index (QTVI) and other repolarization markers in FMF patients with amyloidosis.
  • To investigate potential arrhythmogenic markers in FMF-associated amyloidosis.
  • To compare repolarization markers between FMF amyloidosis patients and healthy controls.

Main Methods:

  • The study included 12 FMF patients with amyloidosis and 14 healthy controls.
  • QT measurements were performed using computerized software.
  • QT variability index (QTVI) and other repolarization parameters were analyzed.

Main Results:

  • No significant differences in QTc or power spectral analysis of QT variability were observed between groups.
  • QTVI was significantly higher in FMF amyloidosis patients compared to healthy controls (P=0.02).
  • Hypertension was more prevalent in the FMF amyloidosis group.

Conclusions:

  • Amyloidosis associated with FMF is linked to an elevated QTVI.
  • The clinical significance and prognostic value of increased QTVI in this population require further investigation.
  • The findings suggest a potential association between FMF amyloidosis and cardiac repolarization abnormalities.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...